Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys

被引:40
作者
Eslamboli, A
Baker, HF
Ridley, RM
Annett, LE
机构
[1] Dept Expt Psychol, Cambridge CB2 3EB, England
[2] Univ Hertfordshire, Dept Psychol, Hatfield AL10 9AB, Herts, England
关键词
marmoset; monkey; Parkinson's disease; 6-hydroxydopamine; dopamine; basal ganglia; substantia nigra; caudate; accumbens; putamen;
D O I
10.1016/S0014-4886(03)00139-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Animal studies investigating the efficacy of neurotrophic factors as treatments for Parkinson's disease (PD) ideally require partial dopamine (DA) lesion models. The intrastriatal 6-hydroxydopamine (6-OHDA) lesion model may be suitable for this purpose. Although this model has been well characterized in rodents, it has not previously been used in monkeys. The goal of the present study was to characterize the behavioral effects of unilateral injections of 6-OHDA in the basal ganglia of common marmoset monkeys (Callithrix jacchus). Cell counts from tyrosine hydroxylase immunochemistry 5 months postlesion revealed DA cell loss in the substantia nigra on the lesioned side to similar to46% of relative to the unlesioned side. 6-OHDA lesioned monkeys showed a variety of behavioral deficits. Apomorphine induced rotation and simple sensorimotor measures (head position bias and PD disability rating score) were most affected by the lesion. The largest deficits were seen at I or 2 weeks postsurgery but had recovered by week 10. 6-OHDA lesioned monkeys took longer to complete a more complex sensorimotor staircase task. At 3.5 months postlesion, 6-OHDA monkeys also showed deficits on an object retrieval task designed to measure sensorimotor planning and skilled hand use. alpha-Methyl-p-tyrosine, a tyrosine hydroxylase inhibitor, reinstated those deficits which had undergone recovery in the lesioned animals and also exacerbated the deficits on the staircase task. This model has potential in assessing treatments for PD aimed at curtailing disease progression such as continuous delivery of neurotrophic factors. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:418 / 429
页数:12
相关论文
共 60 条
[11]   The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease [J].
Damier, P ;
Hirsch, EC ;
Agid, Y ;
Graybiel, AM .
BRAIN, 1999, 122 :1437-1448
[12]   SUCCESSFUL PERFORMANCE BY MONKEYS WITH LESIONS OF THE HIPPOCAMPAL-FORMATION ON ABBAR AND OBJECT RETRIEVAL, 2 TASKS THAT MARK DEVELOPMENTAL-CHANGES IN HUMAN INFANTS [J].
DIAMOND, A ;
ZOLAMORGAN, S ;
SQUIRE, LR .
BEHAVIORAL NEUROSCIENCE, 1989, 103 (03) :526-+
[13]  
DIAMOND A, 1985, Society for Neuroscience Abstracts, V11, P832
[14]   Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease [J].
Durif, F ;
Lemaire, JJ ;
Debilly, B ;
Dordain, G .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (03) :315-322
[15]  
Errea JM, 1999, MOVEMENT DISORD, V14, P596, DOI 10.1002/1531-8257(199907)14:4<596::AID-MDS1008>3.0.CO
[16]  
2-U
[17]   An overview of novel therapies for Parkinson's disease [J].
Fahn, S .
EXPERIMENTAL NEUROLOGY, 1997, 144 (01) :21-23
[18]   Axonal sprouting following lesions of the rat substantia nigra [J].
Finkelstein, DI ;
Stanic, D ;
Parish, CL ;
Tomas, D ;
Dickson, K ;
Horne, MK .
NEUROSCIENCE, 2000, 97 (01) :99-112
[19]   Functional recovery in parkinsonian monkeys treated with GDNF [J].
Gash, DM ;
Zhang, ZM ;
Ovadia, A ;
Cass, WA ;
Yi, A ;
Simmerman, L ;
Russell, D ;
Martin, D ;
Lapchak, PA ;
Collins, F ;
Hoffer, BJ ;
Gerhardt, GA .
NATURE, 1996, 380 (6571) :252-255
[20]   Diagnostic criteria for Parkinson disease [J].
Gelb, DJ ;
Oliver, E ;
Gilman, S .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :33-39